Verastem Total Assets 2011-2023 | VSTM

Verastem total assets from 2011 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
Verastem Annual Total Assets
(Millions of US $)
2023 $150
2022 $95
2021 $109
2020 $154
2019 $145
2018 $277
2017 $90
2016 $84
2015 $113
2014 $99
2013 $125
2012 $93
2011 $59
2010 $4
Verastem Quarterly Total Assets
(Millions of US $)
2023-12-31 $150
2023-09-30 $176
2023-06-30 $192
2023-03-31 $121
2022-12-31 $95
2022-09-30 $111
2022-06-30 $100
2022-03-31 $116
2021-12-31 $109
2021-09-30 $112
2021-06-30 $124
2021-03-31 $137
2020-12-31 $154
2020-09-30 $218
2020-06-30 $199
2020-03-31 $208
2019-12-31 $145
2019-09-30 $193
2019-06-30 $219
2019-03-31 $243
2018-12-31 $277
2018-09-30 $183
2018-06-30 $173
2018-03-31 $68
2017-12-31 $90
2017-09-30 $63
2017-06-30 $62
2017-03-31 $76
2016-12-31 $84
2016-09-30 $89
2016-06-30 $95
2016-03-31 $103
2015-12-31 $113
2015-09-30 $124
2015-06-30 $136
2015-03-31 $142
2014-12-31 $99
2014-09-30 $98
2014-06-30 $107
2014-03-31 $116
2013-12-31 $125
2013-09-30 $132
2013-06-30 $80
2013-03-31 $86
2012-12-31 $93
2012-09-30 $99
2012-06-30 $106
2012-03-31 $111
2011-12-31 $59
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $4
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.291B $0.003B
Verastem, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing drugs to improve outcomes for patients with cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. Its lead FAK inhibitor is defactinib (VS-6063), an orally available candidate for combination therapy with immuno-oncology agents and other anti-cancer compounds. The company's defactinib is in Phase 1b study for the treatment of pancreatic cancer, as well as in Phase 1/2 clinical trial for the treatment of ovarian cancer, non-small cell lung cancer, mesothelioma, and pancreatic cancer. It also engages in developing duvelisib, an investigational oral therapy that targets the PI3K signaling pathway, as well as attacks malignant B-cells and T-cells and disrupt the tumor microenvironment to help thwart their growth and proliferation for patients with lymphatic cancers through the dual inhibition of PI3K delta and gamma.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $167.620B 16.77
Vertex Pharmaceuticals (VRTX) United States $114.888B 29.56
Regeneron Pharmaceuticals (REGN) United States $108.234B 26.47
GSK (GSK) United Kingdom $93.218B 11.13
CSL (CSLLY) Australia $90.861B 0.00
Bristol Myers Squibb (BMY) United States $89.253B 41.93
Gilead Sciences (GILD) United States $84.369B 16.80
Moderna (MRNA) United States $50.933B 0.00
Biogen (BIIB) United States $33.570B 15.37
Argenex SE (ARGX) Netherlands $21.740B 0.00
BioNTech SE (BNTX) Germany $21.540B 181.22
Genmab (GMAB) Denmark $19.824B 23.24
Alnylam Pharmaceuticals (ALNY) United States $18.898B 0.00
Illumina (ILMN) United States $17.693B 126.22
BeiGene (BGNE) Cayman Islands $16.540B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.727B 57.45
Bio-Techne Corp (TECH) United States $13.206B 49.88
Incyte (INCY) United States $12.821B 19.83
Sarepta Therapeutics (SRPT) United States $12.419B 1094.83
QIAGEN (QGEN) Netherlands $10.427B 22.27
Repligen (RGEN) United States $9.607B 125.50
Exact Sciences (EXAS) United States $9.297B 0.00
Roivant Sciences (ROIV) United Kingdom $9.050B 0.00
Legend Biotech (LEGN) United States $8.232B 0.00
Vaxcyte (PCVX) United States $8.113B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.984B 26.11
Viking Therapeutics (VKTX) United States $7.388B 0.00
Ascendis Pharma (ASND) Denmark $7.052B 0.00
Intra-Cellular Therapies (ITCI) United States $6.862B 0.00
Blueprint Medicines (BPMC) United States $6.572B 0.00
Exelixis (EXEL) United States $6.340B 32.67
Cytokinetics (CYTK) United States $6.242B 0.00
Halozyme Therapeutics (HALO) United States $5.690B 15.80
ImmunityBio (IBRX) United States $5.291B 0.00
Apellis Pharmaceuticals (APLS) United States $5.014B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.774B 0.00
Krystal Biotech (KRYS) United States $4.686B 0.00
Nuvalent (NUVL) United States $4.541B 0.00
Zealand Pharma (ZLDPF) Denmark $4.510B 0.00
Immunovant (IMVT) United States $4.460B 0.00
Alkermes (ALKS) Ireland $4.087B 15.99
Insmed (INSM) United States $3.681B 0.00
Axsome Therapeutics (AXSM) United States $3.635B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.515B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.481B 0.00
SpringWorks Therapeutics (SWTX) United States $3.322B 0.00
Biohaven (BHVN) United States $3.299B 0.00
Guardant Health (GH) United States $3.103B 0.00
IDEAYA Biosciences (IDYA) United States $3.065B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.004B 0.00
Apogee Therapeutics (APGE) United States $2.941B 0.00
Denali Therapeutics (DNLI) United States $2.925B 0.00
Arcellx (ACLX) United States $2.869B 0.00
Iovance Biotherapeutics (IOVA) United States $2.865B 0.00
MorphoSys AG (MOR) Germany $2.862B 0.00
Amicus Therapeutics (FOLD) United States $2.835B 0.00
Avidity Biosciences (RNA) United States $2.821B 0.00
Twist Bioscience (TWST) United States $2.737B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.665B 0.00
Certara (CERT) United States $2.586B 59.56
Merus (MRUS) Netherlands $2.577B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.540B 0.00
Intellia Therapeutics (NTLA) United States $2.530B 0.00
Celldex Therapeutics (CLDX) United States $2.518B 0.00
Fortrea Holdings (FTRE) United States $2.462B 30.27
ACADIA Pharmaceuticals (ACAD) United States $2.444B 0.00
Janux Therapeutics (JANX) United States $2.442B 0.00
Vericel (VCEL) United States $2.350B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.315B 0.00
Myriad Genetics (MYGN) United States $2.289B 0.00
Vera Therapeutics (VERA) United States $2.264B 0.00
Geron (GERN) United States $2.260B 0.00
Arvinas (ARVN) United States $2.236B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.202B 0.00
Kymera Therapeutics (KYMR) United States $2.144B 0.00
ADMA Biologics Inc (ADMA) United States $2.102B 83.73
Rocket Pharmaceuticals (RCKT) United States $2.053B 0.00
Beam Therapeutics (BEAM) United States $2.027B 0.00
Bavarian Nordic (BVNRY) Denmark $2.026B 8.82
CG Oncology (CGON) United States $1.998B 0.00
Galapagos (GLPG) Belgium $1.953B 0.00
Sana Biotechnology (SANA) United States $1.934B 0.00
Zai Lab (ZLAB) China $1.925B 0.00
NeoGenomics (NEO) United States $1.890B 0.00
Keros Therapeutics (KROS) United States $1.886B 0.00
Novavax (NVAX) United States $1.827B 0.00
Inhibrx (INBX) United States $1.818B 0.00
Protagonist Therapeutics (PTGX) United States $1.803B 12.60
Ginkgo Bioworks Holdings (DNA) United States $1.734B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.724B 0.00
Edgewise Therapeutics (EWTX) United States $1.691B 0.00
Kura Oncology (KURA) United States $1.689B 0.00
Structure Therapeutics (GPCR) United States $1.685B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.649B 12.57
Ligand Pharmaceuticals (LGND) United States $1.549B 25.31
Neumora Therapeutics (NMRA) United States $1.543B 0.00
Arcus Biosciences (RCUS) United States $1.537B 0.00
Spyre Therapeutics (SYRE) United States $1.523B 0.00
Morphic Holding (MORF) United States $1.464B 0.00
Dynavax Technologies (DVAX) United States $1.454B 185.17
Tarsus Pharmaceuticals (TARS) United States $1.445B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.413B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.402B 0.00
Akero Therapeutics (AKRO) United States $1.377B 0.00
Belite Bio (BLTE) United States $1.340B 0.00
Vir Biotechnology (VIR) United States $1.324B 0.00
ANI Pharmaceuticals (ANIP) United States $1.288B 16.00
MannKind (MNKD) United States $1.250B 153.00
Gyre Therapeutics (GYRE) United States $1.218B 0.00
Prothena (PRTA) Ireland $1.211B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.167B 0.00
MiMedx (MDXG) United States $1.151B 48.75
Mirum Pharmaceuticals (MIRM) United States $1.134B 0.00
AbCellera Biologics (ABCL) Canada $1.070B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.065B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.051B 0.00
Cullinan Therapeutics (CGEM) United States $0.998B 0.00
Scholar Rock Holding (SRRK) United States $0.996B 0.00
Liquidia Technologies (LQDA) United States $0.971B 0.00
Tyra Biosciences (TYRA) United States $0.959B 0.00
Immatics (IMTX) Germany $0.928B 0.00
Pliant Therapeutics (PLRX) United States $0.921B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.914B 0.00
Viridian Therapeutics (VRDN) United States $0.858B 0.00
Abivax SA (ABVX) France $0.858B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.857B 0.00
Prime Medicine (PRME) United States $0.850B 0.00
89BIO (ETNB) United States $0.849B 0.00
Mesoblast (MESO) Australia $0.839B 0.00
Immunome (IMNM) United States $0.829B 0.00
Nurix Therapeutics (NRIX) United States $0.815B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.804B 0.00
CARGO Therapeutics (CRGX) United States $0.804B 0.00
Tango Therapeutics (TNGX) United States $0.803B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.802B 0.00
Cytek Biosciences (CTKB) United States $0.801B 0.00
Disc Medicine (IRON) United States $0.794B 0.00
REGENXBIO (RGNX) United States $0.788B 0.00
HilleVax (HLVX) United States $0.788B 0.00
CureVac (CVAC) Germany $0.781B 0.00
Praxis Precision Medicines (PRAX) United States $0.777B 0.00
PureTech Health (PRTC) United States $0.776B 0.00
WAVE Life Sciences (WVE) Singapore $0.767B 0.00
Humacyte (HUMA) United States $0.754B 0.00
Dianthus Therapeutics (DNTH) United States $0.752B 0.00
ALX Oncology Holdings (ALXO) United States $0.740B 0.00
Stoke Therapeutics (STOK) United States $0.724B 0.00
Nuvation Bio (NUVB) United States $0.724B 0.00
Cogent Biosciences (COGT) United States $0.711B 0.00
AnaptysBio (ANAB) United States $0.685B 0.00
ArriVent BioPharma (AVBP) United States $0.673B 0.00
Castle Biosciences (CSTL) United States $0.669B 0.00
Kyverna Therapeutics (KYTX) United States $0.665B 0.00
GH Research (GHRS) Ireland $0.656B 0.00
ITeos Therapeutics (ITOS) United States $0.652B 0.00
Mineralys Therapeutics (MLYS) United States $0.645B 0.00
Zymeworks (ZYME) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Pharming Group (PHAR) Netherlands $0.626B 0.00
Pharming Group (PHGUF) Netherlands $0.622B 0.00
Oric Pharmaceuticals (ORIC) United States $0.618B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.617B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.617B 0.00
Cabaletta Bio (CABA) United States $0.596B 0.00
Aerovate Therapeutics (AVTE) United States $0.593B 0.00
Avid Bioservices (CDMO) United States $0.579B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.578B 0.00
Third Harmonic Bio (THRD) United States $0.568B 0.00
EnGene Holdings (ENGN) United States $0.566B 0.00
Northwest Biotherapeutics (NWBO) United States $0.564B 0.00
Arbutus Biopharma (ABUS) United States $0.562B 0.00
Olema Pharmaceuticals (OLMA) United States $0.550B 0.00
IGM Biosciences (IGMS) United States $0.544B 0.00
Adaptive Biotechnologies (ADPT) United States $0.532B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
Alector (ALEC) United States $0.524B 0.00
Astria Therapeutics (ATXS) United States $0.524B 0.00
Celcuity (CELC) United States $0.523B 0.00
Absci (ABSI) United States $0.522B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.509B 0.00
Entrada Therapeutics (TRDA) United States $0.506B 23.79
Ocugen (OCGN) United States $0.492B 0.00
Adlai Nortye (ANL) Cayman Islands $0.489B 0.00
MaxCyte (MXCT) United States $0.488B 0.00
Oculis Holding AG (OCS) Switzerland $0.485B 0.00
Applied Therapeutics (APLT) United States $0.479B 0.00
TScan Therapeutics (TCRX) United States $0.475B 0.00
Allogene Therapeutics (ALLO) United States $0.473B 0.00
Fulcrum Therapeutics (FULC) United States $0.469B 0.00
Editas Medicine (EDIT) United States $0.462B 0.00
Travere Therapeutics (TVTX) United States $0.461B 0.00
Voyager Therapeutics (VYGR) United States $0.459B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.449B 0.00
Fate Therapeutics (FATE) United States $0.444B 0.00
Biomea Fusion (BMEA) United States $0.440B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.436B 0.00
ACELYRIN, INC (SLRN) United States $0.435B 0.00
Neurogene (NGNE) United States $0.432B 0.00
PepGen (PEPG) United States $0.427B 0.00
Annexon (ANNX) United States $0.400B 0.00
Replimune (REPL) United States $0.396B 0.00
C4 Therapeutics (CCCC) United States $0.391B 0.00
Anavex Life Sciences (AVXL) United States $0.385B 0.00
Terns Pharmaceuticals (TERN) United States $0.382B 0.00
Anika Therapeutics (ANIK) United States $0.377B 317.50
Shattuck Labs (STTK) United States $0.376B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.372B 0.00
FibroBiologics (FBLG) United States $0.371B 0.00
Nautilus Biotechnology (NAUT) United States $0.370B 0.00
MeiraGTx Holdings (MGTX) United States $0.367B 0.00
Tenaya Therapeutics (TNYA) United States $0.366B 0.00
Aura Biosciences (AURA) United States $0.360B 0.00
Amarin (AMRN) Ireland $0.357B 0.00
Precigen (PGEN) United States $0.348B 0.00
Jasper Therapeutics (JSPR) United States $0.347B 0.00
Solid Biosciences (SLDB) United States $0.344B 0.00
Candel Therapeutics (CADL) United States $0.342B 0.00
Erasca (ERAS) United States $0.342B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.339B 0.00
Skye Bioscience (SKYE) United States $0.338B 0.00
Alto Neuroscience (ANRO) United States $0.335B 0.00
Mersana Therapeutics (MRSN) United States $0.334B 0.00
Ventyx Biosciences (VTYX) United States $0.333B 0.00
Sutro Biopharma (STRO) United States $0.328B 0.00
Nkarta (NKTX) United States $0.323B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.319B 0.00
Revance Therapeutics (RVNC) United States $0.315B 0.00
AC Immune (ACIU) Switzerland $0.315B 0.00
Inovio Pharmaceuticals (INO) United States $0.311B 0.00
Urogen Pharma (URGN) United States $0.310B 0.00
Poseida Therapeutics (PSTX) United States $0.309B 0.00
Kamada (KMDA) Israel $0.309B 23.35
Atea Pharmaceuticals (AVIR) United States $0.307B 0.00
Caribou Biosciences (CRBU) United States $0.306B 0.00
XOMA (XOMA) United States $0.297B 0.00
Emergent Biosolutions (EBS) United States $0.291B 0.00
Invivyd (IVVD) United States $0.286B 0.00
Inozyme Pharma (INZY) United States $0.285B 0.00
23andMe Holding (ME) United States $0.283B 0.00
Contineum Therapeutics (CTNM) United States $0.283B 0.00
CorMedix Inc (CRMD) United States $0.281B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.274B 0.00
Rani Therapeutics Holdings (RANI) United States $0.263B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.263B 0.00
Zura Bio (ZURA) United States $0.261B 0.00
Prima BioMed (IMMP) Australia $0.260B 0.00
XBiotech (XBIT) United States $0.257B 0.00
Codexis (CDXS) United States $0.255B 0.00
ChromaDex (CDXC) United States $0.249B 0.00
Design Therapeutics (DSGN) United States $0.249B 0.00
2seventy Bio (TSVT) United States $0.247B 0.00
UniQure (QURE) Netherlands $0.243B 0.00
Coherus BioSciences (CHRS) United States $0.243B 0.00
G1 Therapeutics (GTHX) United States $0.237B 0.00
Agenus (AGEN) United States $0.228B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.224B 0.00
Ovid Therapeutics (OVID) United States $0.223B 0.00
Compass Therapeutics (CMPX) United States $0.220B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.219B 0.00
Innate Pharma S.A (IPHA) France $0.219B 0.00
Boundless Bio (BOLD) $0.215B 0.00
INmune Bio (INMB) United States $0.215B 0.00
Werewolf Therapeutics (HOWL) United States $0.205B 0.00
Opthea (OPT) Australia $0.199B 0.00
Inventiva S.A (IVA) France $0.199B 0.00
Puma Biotechnology (PBYI) United States $0.198B 12.41
Elevation Oncology (ELEV) United States $0.197B 0.00
Trevi Therapeutics (TRVI) United States $0.195B 0.00
GENFIT S.A (GNFT) France $0.187B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.186B 0.00
Compugen (CGEN) Israel $0.183B 0.00
Greenwich LifeSciences (GLSI) United States $0.180B 0.00
Lifecore Biomedical (LFCR) United States $0.178B 0.00
Kodiak Sciences (KOD) United States $0.173B 0.00
ScPharmaceuticals (SCPH) United States $0.171B 0.00
Alimera Sciences (ALIM) United States $0.168B 0.00
Adverum Biotechnologies (ADVM) United States $0.167B 0.00
Cellectis S.A (CLLS) France $0.166B 0.00
Scilex Holding (SCLX) United States $0.163B 0.00
Cardiff Oncology (CRDF) United States $0.162B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.158B 0.00
Gossamer Bio (GOSS) United States $0.157B 0.00
X4 Pharmaceuticals (XFOR) United States $0.156B 0.00
TELA Bio (TELA) United States $0.155B 0.00
Repare Therapeutics (RPTX) Canada $0.151B 0.00
CervoMed (CRVO) United States $0.149B 0.00
Sagimet Biosciences (SGMT) United States $0.147B 0.00
CytomX Therapeutics (CTMX) United States $0.147B 9.45
Syros Pharmaceuticals (SYRS) United States $0.146B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.143B 0.00
Renovaro (RENB) United States $0.143B 0.00
I-Mab (IMAB) China $0.142B 0.00
Cartesian Therapeutics (RNAC) United States $0.141B 0.00
Rapt Therapeutics (RAPT) United States $0.141B 0.00
Akoya Biosciences (AKYA) United States $0.141B 0.00
Seres Therapeutics (MCRB) United States $0.139B 0.00
ATyr Pharma (LIFE) United States $0.138B 0.00
Molecular Partners AG (MOLN) Switzerland $0.137B 0.00
Seer (SEER) United States $0.137B 0.00
BioAtla (BCAB) United States $0.136B 0.00
Sangamo Therapeutics (SGMO) United States $0.135B 0.00
Omega Therapeutics (OMGA) United States $0.133B 0.00
BioStem Technologies (BSEM) $0.133B 0.00
Vigil Neuroscience (VIGL) United States $0.132B 0.00
Adicet Bio (ACET) United States $0.131B 0.00
PDS Biotechnology (PDSB) United States $0.128B 0.00
Coya Therapeutics (COYA) United States $0.128B 0.00
Allakos (ALLK) United States $0.128B 0.00
Vor Biopharma (VOR) $0.124B 0.00
Abeona Therapeutics (ABEO) United States $0.120B 0.00
DiaMedica Therapeutics (DMAC) United States $0.120B 0.00
VistaGen Therapeutics (VTGN) United States $0.120B 0.00
Nuvectis Pharma (NVCT) United States $0.113B 0.00
Bluebird Bio (BLUE) United States $0.113B 0.00
DBV Technologies S.A (DBVT) France $0.113B 0.00
Adagene (ADAG) China $0.113B 0.00
Immunic (IMUX) United States $0.112B 0.00
BioHarvest Sciences (CNVCF) Canada $0.112B 0.00
Rezolute (RZLT) United States $0.106B 0.00
BeyondSpring (BYSI) United States $0.104B 0.00
Elicio Therapeutics (ELTX) United States $0.103B 0.00
Oncobiologics (OTLK) United States $0.101B 0.00
Q32 Bio (QTTB) United States $0.099B 0.00
Genelux (GNLX) United States $0.099B 0.00
Connect Biopharma Holdings (CNTB) United States $0.098B 0.00
Clearside Biomedical (CLSD) United States $0.098B 0.00
Athira Pharma (ATHA) United States $0.097B 0.00
InflaRx (IFRX) Germany $0.096B 0.00
China Health Industries Holdings (CHHE) China $0.095B 0.00
Eton Pharmaceuticals (ETON) United States $0.093B 90.50
Annovis Bio (ANVS) United States $0.093B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.093B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.092B 0.00
YS Biopharma (YS) China $0.091B 0.00
IO Biotech (IOBT) Denmark $0.091B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.091B 0.00
Benitec Biopharma (BNTC) United States $0.089B 0.00
Precision BioSciences (DTIL) United States $0.086B 0.00
Spero Therapeutics (SPRO) United States $0.086B 3.12
Gritstone Bio (GRTS) United States $0.085B 0.00
Galena Biopharma (SLS) United States $0.084B 0.00
Oncolytics Biotech (ONCY) Canada $0.084B 0.00
VTv Therapeutics (VTVT) United States $0.084B 0.00
Cue Biopharma (CUE) United States $0.083B 0.00
Aileron Therapeutics (ALRN) United States $0.081B 0.00
Passage Bio (PASG) United States $0.081B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.081B 0.00
HOOKIPA Pharma (HOOK) United States $0.081B 0.00
Elutia (ELUT) United States $0.080B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.080B 0.00
Affimed (AFMD) Germany $0.080B 0.00
Cognition Therapeutics (CGTX) United States $0.079B 0.00
BioXcel Therapeutics (BTAI) United States $0.078B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.077B 0.00
Bionano Genomics (BNGO) United States $0.076B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.075B 0.00
Instil Bio (TIL) United States $0.075B 0.00
Atara Biotherapeutics (ATRA) United States $0.073B 0.00
Rallybio (RLYB) United States $0.073B 0.00
Alpha Teknova (TKNO) United States $0.073B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.073B 0.00
Entera Bio (ENTX) Israel $0.070B 0.00
Landos Biopharma (LABP) United States $0.070B 0.00
MediciNova (MNOV) United States $0.070B 0.00
Curis (CRIS) United States $0.070B 0.00
Ikena Oncology (IKNA) United States $0.069B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.068B 0.00
AN2 Therapeutics (ANTX) United States $0.068B 0.00
Leap Therapeutics (LPTX) United States $0.067B 0.00
Checkpoint Therapeutics (CKPT) United States $0.067B 0.00
Intensity Therapeutics (INTS) United States $0.067B 0.00
Immix Biopharma (IMMX) United States $0.065B 0.00
Lantern Pharma (LTRN) United States $0.065B 0.00
AVROBIO (AVRO) United States $0.062B 0.00
Turnstone Biologics (TSBX) United States $0.062B 0.00
Kronos Bio (KRON) United States $0.061B 0.00
Ocean Biomedical (OCEA) United States $0.061B 0.00
Theratechnologies (THTX) Canada $0.061B 0.00
Earth Science Tech (ETST) United States $0.060B 0.00
Genenta Science S.p.A (GNTA) Italy $0.060B 0.00
LENZ Therapeutics (LENZ) United States $0.060B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.060B 0.00
CalciMedica (CALC) United States $0.059B 0.00
Celularity (CELU) United States $0.058B 0.00
Enzo Biochem (ENZ) United States $0.056B 0.00
Kezar Life Sciences (KZR) United States $0.056B 0.00
Equillium (EQ) United States $0.055B 0.00
Aligos Therapeutics (ALGS) United States $0.054B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.053B 0.00
Cidara Therapeutics (CDTX) United States $0.051B 0.00
Beyond Air (XAIR) United States $0.049B 0.00
Dare Bioscience (DARE) United States $0.049B 0.00
ARCA Biopharma (ABIO) United States $0.048B 0.00
Dyadic (DYAI) United States $0.048B 0.00
Clene (CLNN) United States $0.048B 0.00
Aadi Bioscience (AADI) United States $0.047B 0.00
NextCure (NXTC) United States $0.047B 0.00
IN8bio (INAB) United States $0.045B 0.00
OKYO Pharma (OKYO) $0.044B 0.00
Ocuphire Pharma (OCUP) United States $0.044B 0.00
Immuneering (IMRX) United States $0.044B 0.00
Xilio Therapeutics (XLO) United States $0.042B 0.00
HCW Biologics (HCWB) United States $0.042B 0.00
Cara Therapeutics (CARA) United States $0.041B 0.00
Lexaria Bioscience (LEXX) Canada $0.041B 0.00
Eyenovia (EYEN) United States $0.040B 0.00
Cyclo Therapeutics (CYTH) United States $0.040B 0.00
Carmell (CTCX) United States $0.039B 0.00
Quince Therapeutics (QNCX) United States $0.039B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.039B 0.00
Fortress Biotech (FBIO) United States $0.038B 0.00
Sensei Biotherapeutics (SNSE) United States $0.038B 0.00
Estrella Immunopharma (ESLA) United States $0.037B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.036B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.036B 0.00
MiNK Therapeutics (INKT) United States $0.035B 0.00
Promis Neurosciences (PMN) Canada $0.035B 0.00
SAB Biotherapeutics (SABS) United States $0.033B 0.00
Pluri (PLUR) Israel $0.033B 0.00
RenovoRx (RNXT) United States $0.033B 0.00
Spruce Biosciences (SPRB) United States $0.031B 0.00
Bolt Biotherapeutics (BOLT) United States $0.030B 0.00
Apollomics (APLM) United States $0.030B 0.00
Aprea Therapeutics (APRE) United States $0.029B 0.00
Femasys (FEMY) United States $0.028B 0.00
Evogene (EVGN) Israel $0.027B 0.00
BioAffinity Technologies (BIAF) United States $0.026B 0.00
Biora Therapeutics (BIOR) United States $0.026B 0.00
NKGen Biotech (NKGN) United States $0.025B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.023B 0.00
BRIACELL THERAP (BCTX) Canada $0.022B 0.00
Forte Biosciences (FBRX) United States $0.022B 0.00
Lumos Pharma (LUMO) United States $0.021B 0.00
Evaxion Biotech (EVAX) Denmark $0.020B 0.00
Cocrystal Pharma (COCP) United States $0.020B 0.00
Synlogic (SYBX) United States $0.019B 0.00
Aptose Biosciences (APTO) Canada $0.019B 0.00
Orgenesis (ORGS) United States $0.019B 0.00
KALA BIO (KALA) United States $0.018B 0.00
VBI Vaccines (VBIV) United States $0.018B 0.00
Senti Biosciences (SNTI) United States $0.017B 0.00
Galecto (GLTO) Denmark $0.017B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.017B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Vincerx Pharma (VINC) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.014B 0.00
Purple Biotech (PPBT) Israel $0.014B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Imunon (IMNN) United States $0.013B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.013B 0.00
Semper Paratus Acquisition (TVGN) United States $0.013B 0.00
Elevai Labs (ELAB) United States $0.013B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.012B 0.00
Moleculin Biotech (MBRX) United States $0.012B 0.00
ABVC BioPharma (ABVC) United States $0.011B 0.00
Eterna Therapeutics (ERNA) United States $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
Galera Therapeutics (GRTX) United States $0.011B 0.00
Monopar Therapeutics (MNPR) United States $0.011B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.010B 0.00
NuCana (NCNA) United Kingdom $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Chemomab Therapeutics (CMMB) Israel $0.009B 0.00
Biorestorative Therapies (BRTX) United States $0.009B 0.00
Vaccinex (VCNX) United States $0.009B 0.00
Kintara Therapeutics (KTRA) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Psyence Biomedical (PBM) United States $0.008B 0.00
Telesis Bio (TBIO) United States $0.008B 0.00
Trevena (TRVN) United States $0.007B 0.00
Bionomics (BNOX) Australia $0.007B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.007B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.007B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Virios Therapeutics (VIRI) United States $0.007B 0.00
TFF Pharmaceuticals (TFFP) United States $0.007B 0.00
Atrinsic (PTIX) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Palisade Bio (PALI) United States $0.006B 0.00
Synaptogenix (SNPX) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.006B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Kineta (KA) United States $0.006B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Cingulate (CING) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
ThermoGenesis Holdings (THMO) United States $0.005B 0.00
Novogen (KZIA) Australia $0.005B 0.00
Artelo Biosciences (ARTL) United States $0.005B 0.00
NexImmune (NEXI) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Alzamend Neuro (ALZN) United States $0.004B 0.00
Exicure (XCUR) United States $0.004B 0.23
Tharimmune (THAR) United States $0.004B 0.00
Seelos Therapeutics (SEEL) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.41
TC BioPharm (Holdings) (TCBP) United Kingdom $0.004B 0.00
Onconetix (ONCO) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
Mustang Bio (MBIO) United States $0.003B 0.00
Longeveron (LGVN) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.003B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
GRI Bio (GRI) United States $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Sunshine Biopharma (SBFM) United States $0.001B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00